Genoway SA
PAR:ALGEN

Watchlist Manager
Genoway SA Logo
Genoway SA
PAR:ALGEN
Watchlist
Price: 3.46 EUR 2.67% Market Closed
Market Cap: 31.2m EUR
Have any thoughts about
Genoway SA?
Write Note

P/OCF
Price to OCF

-40.1
Current
-44.9
Median
23.4
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-40.1
=
Market Cap
30.4m EUR
/
Operating Cash Flow
-759.1k EUR
All Countries
Close
Market Cap P/OCF
FR
Genoway SA
PAR:ALGEN
30.4m EUR -40.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -232 609.5
US
Abbvie Inc
NYSE:ABBV
352.5B USD 21.4
US
Amgen Inc
NASDAQ:AMGN
174.8B USD 24.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
133.2B USD -141.1
US
Gilead Sciences Inc
NASDAQ:GILD
120.3B USD 12
US
Epizyme Inc
F:EPE
94.1B EUR -483.6
AU
CSL Ltd
ASX:CSL
137.9B AUD 32.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
91.2B USD 21.5
US
Seagen Inc
F:SGT
39.3B EUR -78.1
NL
argenx SE
XBRU:ARGX
33.2B EUR -136.9
 
FR
Genoway SA
PAR:ALGEN
Average P/OCF: 22.4
Negative Multiple: -40.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -232 609.5
US
Abbvie Inc
NYSE:ABBV
21.4
US
Amgen Inc
NASDAQ:AMGN
24.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -141.1
US
Gilead Sciences Inc
NASDAQ:GILD
12
US
E
Epizyme Inc
F:EPE
Negative Multiple: -483.6
AU
CSL Ltd
ASX:CSL
32.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
21.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -78.1
NL
argenx SE
XBRU:ARGX
Negative Multiple: -136.9

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More